demonstrated that HBV-related HCC was related to the dysregulation of insulin-IGF-1/IGFBP function and that the overexpression of IGF2 accelerated the formation of liver tumors with the hepatic expression of MYC and AKT1. This evidence concerns the gene AKT1 and hepatocellular carcinoma.